Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leucogen”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03156790
What this trial is testing

PK, PD, Safety and Immunogenicity of Spectrila in Adults With Acute B-cell Lymphoblastic Leukaemia

Who this might be right for
Acute B-Cell Lymphoblastic Leukaemia
medac GmbH 40
Early research (Phase 1)Study completedNCT02283190
What this trial is testing

1336GCC: Study of Erwinaze for Treatment of Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Ashkan Emadi 5
Testing effectiveness (Phase 2)Ended earlyNCT00882206
What this trial is testing

Pre-reinductive Decitabine and Vorinostat in Relapsed Lymphoblastic Lymphoma or Acute Lymphoblastic Leukemia

Who this might be right for
LeukemiaLymphoma
Masonic Cancer Center, University of Minnesota 15
Early research (Phase 1)Study completedNCT00866307
What this trial is testing

Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011)

Who this might be right for
Acute Lymphoblastic LeukemiaAdult B Acute Lymphoblastic LeukemiaChildhood B Acute Lymphoblastic Leukemia
Children's Oncology Group 104
Not applicableNo Longer AvailableNCT00590915
What this trial is testing

Erwinase Master Treatment Protocol

Who this might be right for
Leukemia, Acute LymphoblasticAcute Lymphoid Leukemia
Phoenix Children's Hospital
Post-approval studies (Phase 4)UnknownNCT03071822
What this trial is testing

Combination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide and Dexamethasone as Treatment of Newly Diagnosed and Relapsed/Refractory Peripheral T Cell Lymphomas

Who this might be right for
Peripheral T Cell Lymphoma
The University of Hong Kong 50
Large-scale testing (Phase 3)Study completedNCT04145531
What this trial is testing

An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)

Who this might be right for
Acute Lymphoblastic LeukemiaLymphoblastic Leukemia
Jazz Pharmaceuticals 229
Post-approval studies (Phase 4)UnknownNCT01990807
What this trial is testing

Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic Leukemia

Who this might be right for
Childhood Acute Lymphoblastic LeukemiaPhiladelphia Chromosome, Ph^1^, AbsentB-cell Childhood Acute Lymphoblastic Leukemia
Chinese Academy of Medical Sciences 20
Not applicableLooking for participantsNCT03568266
What this trial is testing

Pharmacogenomics of Asparaginase Induced Hepatotoxicity

Who this might be right for
Acute Lymphoblastic Leukemia
University of Southern California 500
Large-scale testing (Phase 3)Study completedNCT03665441
What this trial is testing

Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment in PAC

Who this might be right for
Pancreatic Adenocarcinoma
ERYtech Pharma 512
Testing effectiveness (Phase 2)Ended earlyNCT01251809
What this trial is testing

Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia

Who this might be right for
Acute Lymphoblastic Leukaemia
medac GmbH 56
Testing effectiveness (Phase 2)Ended earlyNCT01005914
What this trial is testing

Pegaspargase and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
OHSU Knight Cancer Institute 11
Testing effectiveness (Phase 2)Study completedNCT01643408
What this trial is testing

Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy

Who this might be right for
Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma
Jazz Pharmaceuticals 30
Testing effectiveness (Phase 2)Study completedNCT00983138
What this trial is testing

Efficacy and Safety of Recombinant Asparaginase in Infants With Previously Untreated Acute Lymphoid Leukemia (ALL)

Who this might be right for
Acute Lymphoid Leukemia
medac GmbH 12
Not applicableStudy completedNCT06195735
What this trial is testing

Forecasting Hypersensitivity Against PEG-asparaginase to Optimize Outcome in ALL

Who this might be right for
Acute Lymphoblastic Leukemia
Aarhus University Hospital 649
Testing effectiveness (Phase 2)Study completedNCT01810705
What this trial is testing

GRASPA Treatment for Patients With Acute Myeloblastic Leukemia

Who this might be right for
Acute Myeloid Leukemia
ERYtech Pharma 123
Testing effectiveness (Phase 2)Study completedNCT01238159
What this trial is testing

Concomitant Chemo-radiotherapy Followed by MIDLE Chemotherapy in Stage I/II Extranodal NK/T-cell Lymphoma

Who this might be right for
Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
Samsung Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00002665
What this trial is testing

SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia

Who this might be right for
LeukemiaNeutropeniaThrombocytopenia
SWOG Cancer Research Network 50
Testing effectiveness (Phase 2)Study completedNCT00905034
What this trial is testing

Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia (ALL) Salvage

Who this might be right for
Leukemia, Lymphocytic, Acute
M.D. Anderson Cancer Center 37
Not applicableNot Yet RecruitingNCT07499336
What this trial is testing

UNDERSTANDING THE T-CELL AND B-CELL RECEPTOR REPERTOIRE IN CHILDREN AND YOUNG ADULTS WITH ANTI-DRUG ANTIBODIES AGAINST PEG ASPARAGINASE

Who this might be right for
Acute Lymphoblastic Leukaemia - Category
Aarhus University Hospital 45
Next Page